Susquehanna International Group
TEVA icon

Susquehanna International Group’s Teva Pharmaceuticals TEVA Stock Holding History

Susquehanna International Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3M Buy
739,515
+663,802
+877% +$21.4M ﹤0.01% 2091
2025
Q4 		$2.36M Sell
75,713
-750,545
-91% -$18.5M ﹤0.01% 5296
2025
Q3 		$16.7M Sell
826,258
-1,630,876
-66% -$28.6M ﹤0.01% 2398
2025
Q2 		$41.2M Sell
2,457,134
-1,172,528
-32% -$18.9M 0.01% 1310
2025
Q1 		$55.8M Buy
3,629,662
+3,570,976
+6,085% +$63.8M 0.01% 964
2024
Q4 		$1.29M Sell
58,686
-467,183
-89% -$8.5M ﹤0.01% 6331
2024
Q3 		$9.48M Buy
525,869
+434,282
+474% +$7.6M ﹤0.01% 2688
2024
Q2 		$1.49M Sell
91,587
-996,666
-92% -$15.4M ﹤0.01% 5684
2024
Q1 		$15.4M Buy
1,088,253
+930,822
+591% +$11.7M ﹤0.01% 2079
2023
Q4 		$1.64M Sell
157,431
-1,097,071
-87% -$10.2M ﹤0.01% 5778
2023
Q3 		$12.8M Sell
1,254,502
-2,520,696
-67% -$23.5M ﹤0.01% 2250
2023
Q2 		$28.4M Buy
3,775,198
+644,036
+21% +$5.22M 0.01% 1407
2023
Q1 		$27.7M Sell
3,131,162
-141,086
-4% -$1.4M 0.01% 1372
2022
Q4 		$29.8M Buy
3,272,248
+55,525
+2% +$484K 0.01% 1200
2022
Q3 		$26M Sell
3,216,723
-1,364,602
-30% -$12.1M 0.01% 1204
2022
Q2 		$34.5M Sell
4,581,325
-1,167,234
-20% -$10.2M 0.01% 1055
2022
Q1 		$54M Sell
5,748,559
-5,192,292
-47% -$43.3M 0.01% 970
2021
Q4 		$87.6M Buy
10,940,851
+15,889
+0.1% +$143K 0.01% 781
2021
Q3 		$106M Buy
10,924,962
+437,907
+4% +$4.1M 0.01% 760
2021
Q2 		$104M Buy
10,487,055
+1,933,435
+23% +$20.5M 0.01% 769
2021
Q1 		$98.7M Buy
8,553,620
+1,602,210
+23% +$18.4M 0.02% 740
2020
Q4 		$67.1M Buy
6,951,410
+2,448,516
+54% +$23.5M 0.01% 856
2020
Q3 		$40.6M Sell
4,502,894
-3,136,484
-41% -$33.2M 0.01% 980
2020
Q2 		$94.2M Buy
7,639,378
+1,060,915
+16% +$12M 0.02% 527
2020
Q1 		$59.1M Sell
6,578,463
-90,425
-1% -$926K 0.02% 586
2019
Q4 		$65.4M Buy
6,668,888
+495,043
+8% +$4.42M 0.02% 670
2019
Q3 		$42.5M Buy
6,173,845
+1,306,927
+27% +$10M 0.01% 834
2019
Q2 		$44.9M Buy
4,866,918
+1,453,617
+43% +$17.5M 0.02% 757
2019
Q1 		$53.5M Buy
+3,413,301
New +$60.2M 0.02% 592
2018
Q2 		– Sell
-457,315
Closed -$9.33M – 10411
2018
Q1 		$7.82M Sell
457,315
-596,985
-57% -$11.7M ﹤0.01% 2039
2017
Q4 		$20M Sell
1,054,300
-5,450,711
-84% -$82M 0.01% 1260
2017
Q3 		$114M Buy
6,505,011
+3,429,987
+112% +$77.2M 0.04% 337
2017
Q2 		$102M Sell
3,075,024
-676,443
-18% -$20.9M 0.04% 342
2017
Q1 		$120M Sell
3,751,467
-27,518
-0.7% -$939K 0.06% 276
2016
Q4 		$137M Buy
3,778,985
+434,552
+13% +$17.3M 0.07% 241
2016
Q3 		$154M Buy
3,344,433
+1,139,241
+52% +$59.4M 0.07% 217
2016
Q2 		$111M Buy
2,205,192
+582,769
+36% +$31M 0.06% 285
2016
Q1 		$86.8M Buy
1,622,423
+1,387,478
+591% +$81.4M 0.05% 354
2015
Q4 		$15.4M Sell
234,945
-856,825
-78% -$53M 0.01% 1358
2015
Q3 		$61.6M Sell
1,091,770
-321,415
-23% -$20.8M 0.03% 528
2015
Q2 		$83.5M Buy
1,413,185
+927,932
+191% +$57.2M 0.04% 470
2015
Q1 		$30.2M Buy
485,253
+380,039
+361% +$22.1M 0.01% 929
2014
Q4 		$6.05M Sell
105,214
-1,202,584
-92% -$67M ﹤0.01% 2629
2014
Q3 		$70.3M Buy
1,307,798
+302,181
+30% +$16M 0.03% 560
2014
Q2 		$52.7M Sell
1,005,617
-1,644,114
-62% -$84M 0.02% 667
2014
Q1 		$140M Sell
2,649,731
-1,103,754
-29% -$51M 0.06% 258
2013
Q4 		$150M Buy
3,753,485
+1,024,680
+38% +$40.3M 0.07% 229
2013
Q3 		$103M Buy
2,728,805
+238,760
+10% +$9.31M 0.05% 298
2013
Q2 		$97.6M Buy
+2,490,045
New +$97M 0.06% 276

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's TEVA Position: Q1 2026 in Review

Susquehanna International Group increased its Teva Pharmaceuticals (TEVA) stake by 877% in Q1 2026, buying an estimated $21.4M and bringing the position to 739,515 shares worth $22.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

Susquehanna International Group first reported a position in TEVA in Q2 2013 and has held it in 49 quarters since. The position peaked at $154M in Q3 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Susquehanna International Group held 739,515 shares of Teva Pharmaceuticals worth $22.3M as of Q1 2026.
  • Susquehanna International Group bought 663,802 Teva Pharmaceuticals shares in Q1 2026, an estimated $21.4M.
  • Teva Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2091 holding.
  • Susquehanna International Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Teva Pharmaceuticals position peaked at $154M in Q3 2016.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.